Indwara ya Lymphoblastique ikaze (T-BYOSE) -03
Ibiranga urubanza:
- Gusuzuma: Indwara ya T-selile lymphoblastique leukemia
- Gutangira n'ibimenyetso: Mata 2020, byerekanwe no kuzunguruka, umunaniro, hamwe no kuva amaraso. Yasuzumwe na T-selile lymphoblastique leukemia ikoresheje igufwa ryamagufwa MICM.
.
- Ku ya 19 Nyakanga 2020: Yakiriye allogeneic hematopoietic stem selile transplantation yatanzwe numuterankunga wumugore (HLA 5/10 Umuterankunga A). Muri gahunda harimo gushyiramo imirasire yumubiri wose (TBI), cyclophosphamide (CY), na etoposide (VP-16). Utugingo ngengabuzima twa periferique twashyizwemo ku ya 24 Nyakanga, hamwe na granulocyte yakira ku munsi +10 hamwe na platel ku munsi +13. Gukurikirana kwa muganga buri gihe nyuma.
- 25 Gashyantare 2021: Gusubiramo amagufwa yongeye kugaragara mugihe cyo gukurikirana.
- Umuti: Gutangira kuvura umunwa thalidomide.
- 8 Werurwe: Yinjiye mu bitaro byacu.
- Amagufwa ya Morphology: 61.5% yaturika.
- Amaraso ya Periferique Itondekanya: guturika 15%.
- Immunophenotyping: 35,25% selile zigaragaza CD99, CD5, CD3dim, CD8dim, CD7, cCD3, CD2dim, HLA-ABC, cbcl-2, CD81, CD38, byerekana lymphocytes T idakuze.
- Isesengura rya Chromosome: 46, XX [9].
- Leukemia Fusion Gene: SIL-TAL1 fusion gene nziza; gupima ingano: SIL-TA.
- Guhinduranya Amaraso Kumubiri: Bibi.
- Isesengura rya Chimerism (nyuma ya HSCT): Ingirabuzimafatizo zikomoka ku baterankunga zingana na 45,78%.
- Tariki ya 11 Werurwe: Ikusanyirizo rya autologique peripheral maraso lymphocytes kumico ya CD7-CART.
- Umuti: VILP (VDS 4mg, IDA 10mg, L-asparaginase 10,000 IU qd x iminsi 4, Dex 9mg q12h x iminsi 9) gahunda ihujwe na thalidomide kugirango igenzure ikibyimba.
- 19 Werurwe: FC regimen chimiotherapie (ibicurane 50mg x iminsi 3, CTX 0.4gx iminsi 3).
- 24 Werurwe (pre-infusion): Amagufwa ya marrow morphologie yerekanaga hyperplasia yo mu cyiciro cya V, hamwe na 22%.
- Amagufa ya marrow Flow Cytometrie: 29.21% selile (ya selile nucleated selile) yerekana CD3, CD5, CD7, CD99, igaragaza igice cCD3, byerekana selile T idakuze.
- Umubare SIL-TAL1 Fusion Gene: 1.913%.
ibisobanuro2